CASI Pharmaceuticals CASI
$ 5.24
-0.95%
Quarterly report 2022-Q3
added 11-14-2022
CASI Pharmaceuticals EV/EBITDA Ratio 2011-2024 | CASI
Annual EV/EBITDA Ratio CASI Pharmaceuticals
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
-26.1 | -10.5 | -6.11 | -8.75 | -20 | -5.21 | -4.43 | -5.6 | -6.08 | -7.04 | -5.98 |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
-4.43 | -26.1 | -9.62 |